Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS)

Molecular and Cellular Endocrinology

Volumn 365, Issue 2, 2013, Pages 223-230

  Scotti, Leopoldina ^a   Abramovich, Dalhia ^a   Pascuali, Natalia ^a   de Zúñiga, Ignacio ^c   Oubiña, Alejandro ^c   Kopcow, Laura ^c   Lange, Soledad ^d   Owen, Gareth ^d   Tesone, Marta ^a,b   Parborell, Fernanda ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Centro Médico PREGNA Medicina Reproductiva   (Argentina)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Angiogenesis; Angiopoietins; OHSS; Ovary

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CHORIONIC GONADOTROPIN; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR D;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; LUTEAL CELL; MAJOR CLINICAL STUDY; NONHUMAN; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RISK FACTOR;

ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; ANTIBODIES; CASE-CONTROL STUDIES; CELL MOVEMENT; CELLS, CULTURED; FEMALE; FOLLICULAR FLUID; HUMANS; LUTEAL CELLS; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTOR, TIE-2;

EID: 84871362646     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.10.022     Document Type: Article

References (51)

1. Abdel-Malak N.A., Srikant C.B., Kristof A.S., Magder S.A., Di Battista J.A., Hussain S.N. Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8. Blood 2008, 111:4145-4154.
2. Aboulghar M.A., Mansour R.T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum. Reprod. Update 2003, 9:275-289.
3. Abramovich D., Parborell F., Tesone M. Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats. Biol. Reprod. 2006, 75:434-441.
4. Abramovich D., Rodriguez C.A., Hernandez F., Tesone M., Parborell F. Spatiotemporal analysis of the protein expression of angiogenic factors and their related receptors during folliculogenesis in rats with and without hormonal treatment. Reproduction 2009, 137:309-320.
5. Agrawal R., Tan S.L., Wild S., Sladkevicius P., Engmann L., Payne N., Bekir J., Campbell S., Conway G., Jacobs H. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil. Steril. 1999, 71:287-293.
6. Artini P.G., Monti M., Fasciani A., Tartaglia M.L., D'Ambrogio G., Genazzani A.R. Correlation between the amount of follicle-stimulating hormone administered and plasma and follicular fluid vascular endothelial growth factor concentrations in women undergoing in vitro fertilization. Gynecol. Endocrinol. 1998, 12:243-247.
7. Budev M.M., Arroliga A.C., Falcone T. Ovarian hyperstimulation syndrome. Crit. Care Med. 2005, 33:S301-S306.
8. Carmeliet P. Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: a goal for therapeutic angiogenesis?. Circ. Res. 2000, 87:176-178.
9. Cascone I., Audero E., Giraudo E., Napione L., Maniero F., Philips M.R., Collard J.G., Serini G., Bussolino F. Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. Blood 2003, 102:2482-2490.
10. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1169.
11. Delvigne A., Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update 2002, 8:559-577.
12. Findlay J.K. Angiogenesis in reproductive tissues. J. Endocrinol. 1986, 111:357-366.
13. Fredriksson L., Li H., Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004, 15:197-204.
14. Geva E., Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil. Steril. 2000, 74:429-438.
15. Goede V., Schmidt T., Kimmina S., Kozian D., Augustin H.G. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 1998, 78:1385-1394.
16. Golan A., Ron-El R., Herman A., Soffer Y., Weinraub Z., Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv. 1989, 44:430-440.
17. Gruemmer R., Motejlek K., Berghaus D., Weich H.A., Neulen J. Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells. Reprod. Biol. Endocrinol. 2005, 3:57.
18. Hanahan D., Christofori G., Naik P., Arbeit J. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur. J. Cancer 1996, 32A:2386-2393.
19. Hazzard T.M., Molskness T.A., Chaffin C.L., Stouffer R.L. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol. Hum. Reprod. 1999, 5:1115-1121.
20. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999, 79:1283-1316.
21. Heldin C.H., Ostman A., Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta 1998, 1378:F79-113.
22. Hellstrom M., Kalen M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
23. Hurliman A.K., Speroff L., Stouffer R.L., Patton P.E., Lee A., Molskness T.A. Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation. Fertil. Steril. 2010, 93:1493-1499.
24. Jones N., Chen S.H., Sturk C., Master Z., Tran J., Kerbel R.S., Dumont D.J. A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function. Mol. Cell Biol. 2003, 23:2658-2668.
25. Kitajima Y., Endo T., Manase K., Nishikawa A., Shibuya M., Kudo R. Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors and vascular permeability of the ovaries of hyperstimulated rats. Fertil. Steril. 2004, 81(Suppl. 1):842-849.
26. Kitajima Y., Endo T., Nagasawa K., Manase K., Honnma H., Baba T., Hayashi T., Chiba H., Sawada N., Saito H. Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5. Endocrinology 2006, 147(2):694-699.
27. Koos R.D. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol. Reprod. 1995, 52:1426-1435.
28. Lee A., Christenson L.K., Stouffer R.L., Burry K.A., Patton P.E. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil. Steril. 1997, 68:305-311.
29. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
30. Master Z., Jones N., Tran J., Jones J., Kerbel R.S., Dumont D.J. Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak. EMBO J. 2001, 20:5919-5928.
31. McClure N., Healy D.L., Rogers P.A., Sullivan J., Beaton L., Haning R.V., Connolly D.T., Robertson D.M. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994, 344:235-236.
32. Molskness T.A., Stouffer R.L., Burry K.A., Gorrill M.J., Lee D.M., Patton P.E. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women. Hum. Reprod. 2004, 19:822-830.
33. Molskness T.A., Stouffer R.L., Burry K.A., Gorrill M.J., Lee D.M., Patton P.E. Circulating levels of total angiopoietin-2 and the soluble Tie-2 receptor in women during ovarian stimulation and early gestation. Fertil. Steril. 2006, 86:1531-1533.
34. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999, 13:9-22.
35. Neulen J., Yan Z., Raczek S., Weindel K., Keck C., Weich H.A., Marme D., Breckwoldt M. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab. 1995, 80:1967-1971.
36. Otrock Z.K., Mahfouz R.A., Makarem J.A., Shamseddine A.I. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol. Dis. 2007, 39:212-220.
37. Parborell F., Abramovich D., Tesone M. Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes. Biol. Reprod. 2008, 78:506-513.
38. Pellicer A., Albert C., Mercader A., Bonilla-Musoles F., Remohi J., Simon C. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil. Steril. 1999, 71:482-489.
39. Phillips H.S., Hains J., Leung D.W., Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 1990, 127:965-967.
40. Redmer D.A., Doraiswamy V., Bortnem B.J., Fisher K., Jablonka-Shariff A., Grazul-Bilska A.T., Reynolds L.P. Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biol. Reprod. 2001, 65:879-889.
41. Reynolds L.P., Redmer D.A. Growth and microvascular development of the uterus during early pregnancy in ewes. Biol. Reprod. 1992, 47:698-708.
42. Reynolds L.P., Grazul-Bilska A.T., Redmer D.A. Angiogenesis in the corpus luteum. Endocrine 2000, 12:1-9.
43. Rizk B., Aboulghar M., Smitz J., Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum. Reprod. Update 1997, 3:255-266.
44. Scotti L., Irusta G., Abramovich D., Tesone M., Parborell F. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome. Mol. Cell Endocrinol. 2011, 335:116-125.
45. Sleer L.S., Taylor C.C. Cell-type localization of platelet-derived growth factors and receptors in the postnatal rat ovary and follicle. Biol. Reprod. 2007, 76:379-390.
46. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
47. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 2000, 6:460-463.
48. Uutela M., Wirzenius M., Paavonen K., Rajantie I., He Y., Karpanen T., Lohela M., Wiig H., Salven P., Pajusola K., Eriksson U., Alitalo K. PDGF-D induces macrophage recruitment, increased interstitial pressure and blood vessel maturation during angiogenesis. Blood 2004, 104:3198-3204.
49. von Otte S., Paletta J.R., Becker S., Konig S., Fobker M., Greb R.R., Kiesel L., Assmann G., Diedrich K., Nofer J.R. Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. J. Biol. Chem. 2006, 281:5398-5405.
50. Wulff C., Wilson H., Largue P., Duncan W.C., Armstrong D.G., Fraser H.M. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J. Clin. Endocrinol. Metab 2000, 85:4302-4309.
51. Yoon S.J., Kim K.H., Chung H.M., Choi D.H., Lee W.S., Cha K.Y., Lee K.A. Gene expression profiling of early follicular development in primordial, primary, and secondary follicles. Fertil. Steril. 2006, 85:193-203.